Clinical trial
A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume…
NCT00285415 · Carilion Clinic, Other · Terminated
Key facts
| NCT number | NCT00285415 |
|---|---|
| Title | A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation |
| Official title | A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation for Stage III/IV Endometrial Carcinoma |
| Lead sponsor | Carilion Clinic, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Endometrial Adenocarcinoma, Stage III A, B, C |
| Intervention type | Drug |
| Interventions | Docetaxel and Carboplatin |
| Enrollment | 46 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Feb 2, 2006 |
| Last update posted | Feb 5, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: